Literature DB >> 22199287

Cytoskeleton network and cellular migration modulated by nuclear-localized receptor tyrosine kinase ROR1.

Hsiao-Chun Tseng1, Hsiao-Wei Kao, Meng-Ru Ho, Yet-Ran Chen, Tin-Wei Lin, Ping-Chiang Lyu, Wen-Chang Lin.   

Abstract

UNLABELLED: Biological functions of receptor tyrosine kinase-like orphan receptor 1 (ROR1) remain to be elucidated due to the lack of identified genuine ligands. Previously, transiently expressed ROR1 was unexpectedly found to exhibit nuclear localization, the functions of which are unknown.
MATERIALS AND METHODS: We constructed nuclear-homing peptidyl-prolyl cis-trans isomerases (FKBP) domain fusion ROR1-expressing cells and used a synthetic dimerizer to specifically activate FKBP-fused ROR1 proteins for subsequent functional characterization.
RESULTS: Activation of nuclear-homing ROR1 by treating cells with AP20187 dimerizer led to significant increase in actin stress fibers and increased cellular migration. Following gene expression microarray analysis, we demonstrated that activated ROR1 affects several genes involved in the regulation of the actin cytoskeleton (radixin (RDX), ezrin (EZR), son of sevenless homolog 2 (SOS2) and caldesmon 1 (CALD1)).
CONCLUSION: Our data indicate that nuclear-localized ROR1 may play an important role in cell migration and cytoskeleton remodeling. This might explain the critical roles of ROR1 in neuron development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22199287

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

Review 1.  The role of Ryk and Ror receptor tyrosine kinases in Wnt signal transduction.

Authors:  Jennifer Green; Roel Nusse; Renée van Amerongen
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-02-01       Impact factor: 10.005

Review 2.  Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.

Authors:  Mei-Kuang Chen; Mien-Chie Hung
Journal:  FEBS J       Date:  2015-07-04       Impact factor: 5.542

Review 3.  Wnt/β-catenin signaling during early vertebrate neural development.

Authors:  David Brafman; Karl Willert
Journal:  Dev Neurobiol       Date:  2017-08-21       Impact factor: 3.964

Review 4.  Alternative splicing within the Wnt signaling pathway: role in cancer development.

Authors:  B Sumithra; Urmila Saxena; Asim Bikas Das
Journal:  Cell Oncol (Dordr)       Date:  2016-01-13       Impact factor: 6.730

5.  Proteomic analysis identifies the E3 ubiquitin ligase Pdzrn3 as a regulatory target of Wnt5a-Ror signaling.

Authors:  Sara E Konopelski Snavely; Michael W Susman; Ryan C Kunz; Jia Tan; Srisathya Srinivasan; Michael D Cohen; Kyoko Okada; Helen Lamb; Shannon S Choi; Edith P Karuna; Michael K Scales; Steven P Gygi; Michael Eldon Greenberg; Hsin-Yi Henry Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205

6.  Immune response profiling identifies autoantibodies specific to Moyamoya patients.

Authors:  Tara K Sigdel; Lorelei D Shoemaker; Rong Chen; Li Li; Atul J Butte; Minnie M Sarwal; Gary K Steinberg
Journal:  Orphanet J Rare Dis       Date:  2013-03-21       Impact factor: 4.123

7.  The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.

Authors:  Mohammad Hojjat-Farsangi; Abdul Salam Khan; Amir Hossein Daneshmanesh; Ali Moshfegh; Asa Sandin; Ladan Mansouri; Marzia Palma; Jeanette Lundin; Anders Österborg; Håkan Mellstedt
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

8.  Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.

Authors:  Claire Henry; Estelle Llamosas; Alexandra Knipprath-Meszaros; Andreas Schoetzau; Ellen Obermann; Maya Fuenfschilling; Rosemarie Caduff; Daniel Fink; Neville Hacker; Robyn Ward; Viola Heinzelmann-Schwarz; Caroline Ford
Journal:  Oncotarget       Date:  2015-11-24

Review 9.  The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention.

Authors:  Kerstin Menck; Saskia Heinrichs; Cornelia Baden; Annalen Bleckmann
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

10.  First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells.

Authors:  M Hojjat-Farsangi; A H Daneshmanesh; A S Khan; J Shetye; F Mozaffari; P Kharaziha; L-S Rathje; P Kokhaei; L Hansson; J Vågberg; S Byström; E Olsson; C Löfberg; C Norström; J Schultz; M Norin; T Olin; A Österborg; H Mellstedt; A Moshfegh
Journal:  Leukemia       Date:  2018-03-27       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.